Wave Life Sciences Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
WVE Nasdaq 2836 wavelifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Wave Life Sciences Ltd.

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE) - Apr 12th, 2026 3:18 pm
Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors - Apr 3rd, 2026 11:45 am
Is This Weight Loss Drug Stock a Buy on the Dip? - Apr 1st, 2026 3:05 pm
Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains? - Apr 1st, 2026 1:19 am
Wave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight Loss - Mar 31st, 2026 12:06 am
Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review - Mar 30th, 2026 5:40 am
Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip? - Mar 27th, 2026 9:57 am
WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks - Mar 27th, 2026 9:24 am
Wave Life Sciences' WVE-007 Shows 'Modest' Weight Reduction in Trial, Wedbush Says - Mar 27th, 2026 9:22 am
Wave Life Sciences Slips as Obesity Data Fails to Convince - Mar 27th, 2026 8:00 am
Wave’s stock crashes 50% on Phase I obesity data - Mar 27th, 2026 6:35 am
WAVE Life Sciences Shares Phase 1 WVE-007 Data Showing Visceral Fat Loss, Muscle Preservation Signal - Mar 26th, 2026 5:35 pm
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints - Mar 26th, 2026 3:50 pm
Wave Life Sciences Crashes 50% As 'Body Composition' Fat-Loss Drug Underwhelms - Mar 26th, 2026 2:08 pm
Update: Wave Life Sciences Shares Fall After Phase 1 Data for Investigational Obesity Therapy - Mar 26th, 2026 12:14 pm
Wave Life Sciences shares plummet on weight loss therapy update - Mar 26th, 2026 10:30 am
Top Midday Stories: Iran Reportedly Sends Formal Response to US Ceasefire Proposal; Corebridge, Equitable to Merge in $22 Billion All-Stock Deal - Mar 26th, 2026 9:38 am
Wave Plunges More Than 50% After Obesity Shot Falls Short - Mar 26th, 2026 7:40 am
Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 - Mar 26th, 2026 5:30 am
Wave crashes on obesity drug update; Kodiak’s reboot pays dividends - Mar 26th, 2026 4:46 am